» Articles » PMID: 26253587

Factors Associated with Aggressive End of Life Cancer Care

Overview
Specialties Critical Care
Oncology
Date 2015 Aug 9
PMID 26253587
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Many patients with cancer experience aggressive care towards the end of life (EOL) despite evidence of an association with poor outcomes such as prolonged pain and overall dissatisfaction with care.

Purpose: To investigate socio-demographic, clinical and community health care service factors associated with aggressive EOL cancer care.

Methods: An analysis of pooled data from two mortality follow-back surveys was performed. Aggressive EOL care was defined as greater than or equal to one of the following indicators occurring during the last 3 months of life: greater than or equal to two emergency department visits, ≥30 days in hospital and death in hospital.

Results: Of the 681 included patients, 50.1% were men and mean age at death was 75 years. The majority of patients (59.3%, 95% confidence interval (CI) 55.6-63.0%) experienced at least one indicator of aggressive EOL care: 29.7% experienced greater than or equal to two ED visits, 17.1% spent ≥30 days in hospital and 37.9% died in hospital. Patients with prostate or haematological cancer were more likely to experience aggressive EOL care (adjusted odds ratio (AOR) 4.36, 95% CI 1.39-13.70, and 4.16, 95% CI 1.38-12.47, respectively, reference group lung cancer). Patients who received greater than five general practitioner (GP) home visits (AOR 0.37, 95% CI 0.17-0.82, reference group no GP visits) or had contact with district nursing (AOR 0.48, 95% CI 0.28-0.83, reference group no contact) or contact with community palliative care services (AOR 0.27, 95% CI 0.15-0.49, reference group no contact) were less likely to experience aggressive EOL care. No association was found between aggressive EOL care and patients' age, gender, marital, financial or health status.

Conclusions: Community health care services, in particular contact with community palliative care, are associated with a significant reduction in the odds of cancer patients receiving aggressive EOL care. Expansion of such services may help address the current capacity crises faced by many acute health care systems.

Citing Articles

Evaluation of Electronic Palliative Care Coordination Systems to support advance care planning for people living with life-threatening conditions (PREPARE): protocol for a multicentre observational study using routinely collected primary and....

Alied M, Law-Clucas S, Allsop M, Ramsenthaler C, May P, Bearne A BMJ Open. 2025; 15(3):e093175.

PMID: 40044196 PMC: 11883539. DOI: 10.1136/bmjopen-2024-093175.


A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed?.

Cherny N, Nortje N, Kelly R, Zimmermann C, Jordan K, Kreye G ESMO Open. 2025; 10(1):104099.

PMID: 39765188 PMC: 11758828. DOI: 10.1016/j.esmoop.2024.104099.


Aggressive end-of-life care in patients with gastrointestinal cancers - a nationwide study from Denmark.

Gerhardt S, Benthien K, Herling S, Villumsen M, Karup P Acta Oncol. 2024; 63:915-923.

PMID: 39582230 PMC: 11609878. DOI: 10.2340/1651-226X.2024.41008.


Predictive factors of basic palliative and hospice care among patients with cancer visiting the emergency department in a Hungarian tertiary care center.

Varga C, Springo Z, Koch M, Prenek L, Porcsa L, Bellyei S Heliyon. 2024; 10(8):e29348.

PMID: 38628765 PMC: 11019194. DOI: 10.1016/j.heliyon.2024.e29348.


Hospitalizations and re-hospitalizations at the end-of-life among cancer patients; a retrospective register data study.

Singh J, Grov E, Turzer M, Stensvold A BMC Palliat Care. 2024; 23(1):39.

PMID: 38350961 PMC: 10863145. DOI: 10.1186/s12904-024-01370-1.


References
1.
Huang J, Boyd C, Tyldesley S, Zhang-Salomons J, Groome P, Mackillop W . Time spent in hospital in the last six months of life in patients who died of cancer in Ontario. J Clin Oncol. 2002; 20(6):1584-92. DOI: 10.1200/JCO.2002.20.6.1584. View

2.
Moller H, Fairley L, Coupland V, Okello C, Green M, Forman D . The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer. 2007; 96(9):1484-8. PMC: 2360166. DOI: 10.1038/sj.bjc.6603746. View

3.
Ho T, Barbera L, Saskin R, Lu H, Neville B, Earle C . Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011; 29(12):1587-91. PMC: 3082976. DOI: 10.1200/JCO.2010.31.9897. View

4.
McPherson C, Addington-Hall J . Judging the quality of care at the end of life: can proxies provide reliable information?. Soc Sci Med. 2002; 56(1):95-109. DOI: 10.1016/s0277-9536(02)00011-4. View

5.
Gomes B, McCrone P, Hall S, Koffman J, Higginson I . Variations in the quality and costs of end-of-life care, preferences and palliative outcomes for cancer patients by place of death: the QUALYCARE study. BMC Cancer. 2010; 10:400. PMC: 2919503. DOI: 10.1186/1471-2407-10-400. View